Abstract
Human selenium-binding protein 1 (SELENBP1) was originally identified as a protein binding selenium, most likely as selenite. SELENBP1 is associated with cellular redox and thiol homeostasis in several respects, including its established role as a methanethiol oxidase that is involved in degradation of methanethiol, a methionine catabolite, generating hydrogen sulfide (H2S) and hydrogen peroxide (H2O2). As both H2S and reactive oxygen species (such as H2O2) are major regulators of Caenorhabditis elegans lifespan and stress resistance, we hypothesized that a SELENBP1 ortholog in C. elegans would likely be involved in regulating these aspects.
Here we characterize Y37A1B.5, a putative selenium-binding protein 1 ortholog in C. elegans with 52% primary structure identity to human SELENBP1. While conferring resistance to toxic concentrations of selenite, Y37A1B.5 also attenuates resistance to oxidative stress and lowers C. elegans lifespan: knockdown of Y37A1B.5 using RNA interference resulted in an approx. 10% increase of C. elegans lifespan and an enhanced resistance against the redox cycler paraquat, as well as enhanced motility. Analyses of transgenic reporter strains suggest hypodermal expression and cytoplasmic localization of Y37A1B.5, whose expression decreases with worm age. We identify the transcriptional coregulator MDT-15 and transcription factor EGL-27 as regulators of Y37A1B.5 levels and show that the lifespan extending effect elicited by downregulation of Y37A1B.5 is independent of known MDT-15 interacting factors, such as DAF-16 and NHR-49. In summary, Y37A1B.5 is an ortholog of SELENBP1 that shortens C. elegans lifespan and lowers resistance against oxidative stress, while allowing for a better survival under toxic selenite concentrations.
Keywords: Selenium-binding protein, Stress signaling, Caenorhabditis elegans, Lifespan
Graphical abstract
Highlights
-
•
Y37A1B.5 is a C. elegans ortholog of human selenium binding protein 1 (SELENBP-1).
-
•
Y37A1B.5 is a cytoplasmic protein predominantly expressed in hypodermal cells.
-
•
Y37A1B.5 knockdown by RNAi causes C. elegans (mean and maximum) lifespan extension.
-
•
Y37A1B.5 enhances selenite resistance but sensitizes towards oxidative stress.
-
•
Expression of Y37A1B.5 is modulated by MDT-15 and EGL-27.
1. Introduction
Selenium (Se) is an essential trace element for humans and animals that is biologically active mostly in the form of selenocysteine built into selenoproteins. The human selenoproteome consists of 25 selenoproteins and includes five glutathione peroxidase (GPx), one methionine sulfoxide reductase (Msr) and three thioredoxin reductase (TrxR) isoform(s), which are involved in the removal of reactive oxygen species (ROS) such as hydroperoxides, the repair of oxidized methionine residues in proteins and the maintenance of cellular and systemic redox homeostasis [[1], [2], [3]]. Adequate Se intake has been associated with protection against oxidative stress-related adverse conditions and diseases such as cancer or inflammatory disorders in humans. On the other hand, Se oversupply causes toxicity, for example through redox cycling and Se compounds thus acting as “pro-oxidants” [[1], [2], [3]].
The nematode Caenorhabditis elegans is an interesting case with respect to selenoprotein and Se biochemistry: whereas the human genome encodes a total of 25 selenoproteins [4], C. elegans has only one selenoprotein, thioredoxin reductase-1 (TRXR1) [5,6]. Although C. elegans expresses a functional machinery allowing for incorporation of selenocysteine into this single protein, deletion of the trxr-1 gene does not only not shorten C. elegans lifespan [7], but also does not affect sensitivity of C. elegans towards toxic effects of inorganic Se compounds on survival, growth and development [8,9]. While trxr-1-deficient nematodes contain considerably less Se compared to wild-type C. elegans when grown under basal conditions without Se supplementation, both strains incorporate Se with similar efficiency upon exposure to selenite [9]. Two further types of Se-containing proteins were described in mammalian cells: those that have non-specifically incorporated selenomethionine instead of methionine and the small group of selenium-binding proteins [10]. The most prominent of the latter is selenium-binding protein 1 (SELENBP1), originally identified as a protein binding Se, most likely as selenite [11]. Neither the mode of selenite binding nor the physiological significance of SELENBP1 have been fully elucidated. Nevertheless, some associations with (patho-)physiological processes were described, including a link to cell differentiation [12,13] and a correlation between low SELENBP1 expression levels in tumor tissue and poor clinical outcome (for review, see Ref. [14]).
Interestingly, SELENBP1 is associated with cellular redox and thiol homeostasis in several respects: (i) specific cysteine residues in SELENBP1 were proposed to mediate selenite binding or the interaction with metal ions [15,16]; (ii) SELENBP1 expression was found to be inversely related to activity and/or expression of the major antioxidant selenoenzyme GPx1 [14,17]; (iii) SELENBP1 was also shown to be involved in controlling the export of glutathione (GSH) from breast cancer cells and thereby affecting cellular resistance against oxidative stress [17]; (iv) lastly, a unique enzymatic activity of SELENBP1 was recently identified [18]. It is a methanethiol oxidase generating hydrogen sulfide (H2S) and hydrogen peroxide (H2O2) from a bacterial methionine degradation product, methyl mercaptan (methanethiol). Both H2S and ROS (such as H2O2) [19] as well as, more generally, redox processes and thiol metabolism [20] are major regulators of C. elegans lifespan and stress resistance. Therefore, we hypothesized that a SELENBP1 ortholog in C. elegans would likely be involved in regulating these aspects.
We here describe Y37A1B.5, a putative C. elegans ortholog of human SELENBP1, and define its role in regulating stress resistance and lifespan.
2. Materials and methods
2.1. Materials
Chemicals were purchased from Sigma-Aldrich (Munich, Germany) or Carl Roth (Karlsruhe, Germany), unless stated otherwise. Primers were obtained from Life Technologies (Darmstadt, Germany).
2.2. C. elegans maintenance and treatments
C. elegans strains were provided by the Caenorhabditis Genetics Center (CGC, University of Minnesota, USA), which is supported by the National Institutes of Health-Office of Research Infrastructure Programs. The following strains were used: wild-type Bristol N2; EU31, skn-1(zu135) IV; CF1038, daf-16(mu86) I; RB1716, nhr-49(ok2165) I. E. coli OP50 was also received from CGC. For knockdown experiments, RNAi clones were derived from the Ahringer library (Source BioScience, Nottingham, UK) [21] and grown using the appropriate antibiotics. Nematodes were grown, maintained and treated at 20°C on nematode growth medium (NGM) agar plates spotted with E. coli OP50 as food source, as described elsewhere [22]. For stress resistance assays, heat-inactivated bacteria (45 min at 65°C) were used.
Synchronized worm populations were used in all experiments. To this end, worms were washed off the plates, then the eggs collected and washed by centrifugation in sterile ultrapure H2O. Eggs were transferred to fresh NGM agar plates and allowed to hatch and grow for 64 h to young adulthood before being transferred to fresh plates for further experiments. For long-term incubations, nematodes were washed off the plates with S-basal buffer daily and were transferred to freshly prepared NGM agar plates to separate nematodes from progeny. Experiments were carried out with young adult worms, 64 h after synchronization, except for two experiments with exposure to RNAi from egg (see Table 2).
Table 2.
Exp. No. | Strain, Treatment | Effect on Life Span | P (vs. Ctrl)b | Median Life Span (Days) | Mean Life Span (Days ± SEM)c | Mean Life Span (%) | Max Life Span (Days ± SEM)c | Max Life Span (%) | No. of Uncen-sored Worms | Total Number of Worms |
---|---|---|---|---|---|---|---|---|---|---|
Knockdown of Y37A1B.5 (starting at young adult stage) | ||||||||||
1 (see Fig. 2C) | N2 /L4440 | 18 | 19.0 ± 0.1 | 100 | 22.0 ± 0.6 | 100 | 184 | 394 | ||
N2 /Y37A1B.5 | ↑ | **** | 20 | 20.5 ± 0.2 | 107.7 | 24.0 ± 0.8 | 109.1 | 218 | 382 | |
2 | N2 /L4440 | 20 | 20.0 ± 0.1 | 100 | 24.0 ± 0.6 | 100 | 332 | 400 | ||
N2 /Y37A1B.5 | ↑ | **** | 22 | 22.2 ± 0.1 | 111.3 | 28.0 ± 1.0 | 116.7 | 359 | 400 | |
3 | N2 /L4440 | 20 | 19.4 ± 0.1 | 100 | 22.8 ± 0.4 | 100 | 284 | 400 | ||
N2 /Y37A1B.5 | ↑ | **** | 20 | 20.2 ± 0.2 | 104.4 | 24.8 ± 0.7 | 108.8 | 320 | 400 | |
4 | N2 /L4440 | 18 | 18.9 ± 0.2 | 100 | 24.0 ± 0.8 | 100 | 283 | 400 | ||
N2 /Y37A1B.5 | ↑ | **** | 22 | 21.8 ± 0.3 | 115.2 | 28.0 ± 1.0 | 116.7 | 365 | 400 | |
Knockdown of Y37A1B.5 (starting from egg) | ||||||||||
1 | N2 /L4440 | 20 | 20.3 ± 0.2 | 100 | 24.4 ± 1.0 | 100 | 249 | 400 | ||
N2 /Y37A1B.5 | = | n.s. | 20 | 20.4 ± 0.3 | 100.9 | 26.4 ± 1.0 | 108.2 | 335 | 400 | |
2 | N2 /L4440 | 18 | 17.9 ± 0.3 | 100 | 21.6 ± 0.4 | 100 | 324 | 400 | ||
N2 /Y37A1B.5 | ↑ | **** | 18 | 18.8 ± 0.1 | 104.9 | 25.2 ± 0.4 | 116.7 | 362 | 400 |
Survival curves for all experiments are provided in Supplemental Figs. S1 and S2.
Control: N2 /L4440; ****P<0.0001; n. s., not significant.
5 technical replicates.
For RNAi experiments, 1 mM isopropyl-β-D-thiogalactoside (IPTG), 100 μg/ml ampicillin and, if necessary, 12.5 μg/ml tetracycline were added to NGM agar. On the evening before the experiment, agar plates were spotted with E. coli HT115 containing the L4440 empty vector (RNAi control) or the respective DNA fragment cloned into the L4440 vector and allowed to dry overnight.
For selenite toxicity assays, worms were treated with Y37A1B.5 RNAi starting at the egg stage for 72 h. Worms were then exposed to sodium selenite (0, 10, 20 or 30 mM) for 17 h in 150 μl of heat-inactivated bacteria suspension and shaken at 900 rpm on an orbital shaker. The assay was performed in triplicates in a 96-well format. After 17 h, viability was scored after transfer onto NGM plates.
2.3. Lifespan assays
Lifespan analyses of nematodes under RNAi conditions were performed using E. coli HT115 containing either L4440 empty vector (control) or the respective DNA fragment in L4440 starting at young adult stage. For the first 10 days, nematodes were transferred to fresh plates daily; thereafter, they were transferred every other day. Worms showing no movement, no reaction to gentle stimulation and no pharyngeal pumping were scored as dead. Worms lost or disintegrated, e.g. due to internal hatchings, were censored. Experiments were performed in multiple technical replicates (usually quintuplicates).
2.4. Stress resistance assays
Following RNAi or control treatment for five days, worms were exposed to the redox cycler paraquat. For paraquat exposure, worms were transferred to plates spotted with heat-inactivated bacteria and containing 300 mM paraquat; survival was scored hourly.
2.5. Assessment of locomotion, body area and body length
Nematodes were exposed to RNAi or control treatment for five, seven (body area, length) or ten (locomotion) days.
On day five or seven, 10 nematodes were transferred to S-basal with 0.1% Triton X-100. Worms were pipetted onto an objective slide and photographs of single worms were taken on an inverted Nikon Eclipse Ti-E fluorescence microscope. Each photograph was analyzed using the Nikon software NIS elements. Ten worms were analyzed for each treatment group, and the experiment was performed at least three times.
On day ten, single nematodes were transferred to S-basal medium containing 0.1% Triton X-100. Single worms were then pipetted, in a drop of 1 μl S-basal, onto an objective slide, and 10-s-movies were recorded under an inverted Nikon Eclipse Ti-E fluorescence microscope. For each treatment group, 10 worms were recorded, and the experiment was performed at least three times. Pathlength analysis was performed using Nikon tracking software (NIS elements).
2.6. Fecundity
64 h after synchronization, ten single nematodes of each treatment group were each transferred to one NGM RNAi agar plate to lay eggs. 24 h later the ten worms were transferred to ten new agar plates spotted with the respective bacteria and again allowed to lay eggs. The procedure was repeated until nematodes ceased to lay eggs. Each time, after transfer of worms, the remaining plates and eggs were placed back to the incubator. Worms (progeny) were allowed to hatch and grow until reaching the L3 larvae stage (48 h) and then counted. The experiment was performed three independent times.
2.7. Quantitative reverse transcription-PCR (qRT-PCR)
Worms were collected and shock-frozen in liquid nitrogen. Worms were lysed in TRIzol reagent (Thermo Scientific) and total RNA was isolated using acid guanidinium thiocyanate-phenol-chloroform extraction. RNA (1 μg) was reversely transcribed using GoScript Reverse Transcriptase (Promega) or RevertAid Reverse Transcriptase (Thermo Scientific), according to the manufacturers’ instructions, and subjected to qPCR analysis using SsoAdvanced Universal SYBR Green Supermix and a CFX Connect cycler (Bio-Rad Laboratories AG, Munich, Germany). Experiments were conducted in triplicates. cdc-42, tba-1 or pmp-3 were used as housekeeping genes for relative quantitation of mRNAs of interest [23]. Sequences of primers used for PCR are compiled in Table 1.
Table 1.
Gene name | Accession No. or Reference | Forward primer | Reverse primer |
---|---|---|---|
Y37A1B.5 | NM_001268848.1 | TTTTAGAATTCATCCTGTTGAGGAG | AAGAGCCCATCCACTTACTTTTT |
mdt-15 | NM_171134.6 | ACGACAGCAGGAAACACTCC | TGATGGAGCAGGCAATCCTC |
egl-27 | NM_171011.3 | CCATCAGGAAGAGCGTGTCA | CACGCTGGAACTTGAGATGG |
cdc-42 | [23] | AGCCATTCTGGCCGCTCTCG | GCAACCGCTTCTCGTTTGGC |
tba-1 | [23] | TCAACACTGCCATCGCCGCC | TCCAAGCGAGACCAGGCTTCAG |
pmp-3 | [23] | TGGCCGGATGATGGTGTCGC | ACGAACAATGCCAAAGGCCAGC |
2.8. RNA sequencing (RNA-Seq)
Sequencing of RNA samples was done following their reverse transcription using Illumina's next-generation sequencing methodology [24]. Specifically, quality check and quantification of total RNA was done using the Agilent Bioanalyzer 2100 in combination with the RNA 6000 nano kit (Agilent Technologies). Approximately 1 μg of total RNA was used for library preparation using the TruSeq stranded mRNA library preparation kit (Illumina) following the manufacturer's description. Quantification and quality check of libraries was done using the Agilent Bioanalyzer 2100 in combination with the DNA 7500 kit. Libraries were sequenced on a HiSeq2500 running in 51cycle/single-end/high-output mode using sequencing chemistry v3. All libraries were pooled and sequenced in three lanes. Sequence information was extracted in FastQ format using Illumina's bcl2fastq v.1.8.4. Sequencing resulted in around 40 ± 4 million reads per sample.
2.9. RNA expression analysis
For expression analysis, the raw RNA-Seq reads were quality-trimmed and filtered for low complexity with the tool preprocess from the SGA assembler (version 0.10.13, parameters -q 30 -m 50 --dust) [25]. The passed reads were mapped to the C. elegans genome (WBcel235, release 90, http://aug2017.archive.ensembl.org/Caenorhabditis_elegans/Info/Annotation) with Ensembl gene annotation using TopHat2 (version 2.1.0; conservative settings, i. e --b2-sensitive --no-coverage-search --no-novel-juncs --no-novel-indels --transcriptome-max-hits = 1) [26]. Next, all reads mapping uniquely to an Ensembl gene were counted using FeatureCounts (version 1.5.0; multi-mapping or multi-overlapping reads were not counted, stranded mode was set to “–s 2”, Ensembl release 90 gene annotation) [27].
The table of raw counts per gene per sample was analyzed with R (version 3.4.1) using the package DESeq2 (version 1.16.1) [28] to test for differential expression. Y37A1B.5 RNAi samples were contrasted with the control samples (L4440 empty vector). For each gene of the comparison, the p-value was calculated using the Wald significance test. Resulting p-values were adjusted for multiple testing with Benjamini & Hochberg correction. Genes with an adjusted p-value <0.05 are considered differentially expressed (DEGs). The log2-fold changes (LFC) were shrunken with lfcShrink to control for variance of LFC estimates for genes with low read counts.
2.10. Pathway enrichment
For the identification of enriched pathways, DEGs were entered in the GEne SeT AnaLysis Toolkit “WebGestalt” (www.webgestalt.org) as a ranked list, with the LFC representing the rank for each DEG. As a threshold for significantly enriched pathways, FDR was set to 0.05. We performed Gene Set Enrichment Analysis (GSEA) using the KEGG pathway database for C. elegans. The normalized enrichment score displays positively (black) and negatively (gray) related categories, which corresponds to up- or downregulated pathways, respectively.
2.11. Generation of transgenic strains
For the generation of a Y37A1B.5 translational reporter construct, a region of 2988 bp upstream of the translation initiation codon ATG (promoter region) and the complete genomic coding sequence of the Y37A1B.5 gene (excluding the translation termination codon) were amplified as a single PCR-fragment from the N2 wildtype worm genomic DNA, using primers with pre-designed BamHI and Cfr9I restriction enzyme sites (see Fig. 3A). The amplified region was digested using BamHI and Cfr9I and inserted into the pPD95_77 empty vector at the BamHI and XmaI sites. pPD95_77 was a gift from Andrew Fire (Addgene plasmid #1495; http://n2t.net/addgene:1495;RRID:Addgene_1495). The final construct pY37A1B.5::Y37A1B.5::gfp was injected into the N2 wildtype strain at 20 ng/μl along with the rol-6(su1006) coinjection marker at 50 ng/μl. Stable transmitting lines were used for image analysis.
2.12. Fluorescence microscopy
Adult nematodes were placed on microscope slides coated with 3% agarose, anaesthetized with 10 mM sodium azide, and covered with coverslips. GFP fluorescence was analyzed on a Nikon Eclipse Ti-E fluorescence microscope using appropriate filters (GFP: ex. 472±30 nm, em. 520±35 nm). Pictures to determine localization were taken on a Zeiss Axio Imager Z2 microscope. For quantitation of the GFP signal intensity, worms were marked as regions of interest (ROI) – either automatically using the binary threshold of the GFP signal or manually using the brightfield overlay image. Total GFP intensity and area of each ROI was then measured and GFP intensity was normalized to worm area and subtracted from background signal to obtain the relative GFP fluorescence intensity for each worm.
For analysis of GFP expression under stress, nematodes showing the roller phenotype were transferred to plates that were spotted with heat-inactivated bacteria containing the respective compound. 24 h later, GFP expression in those worms was analyzed as described above.
2.13. Statistical analysis
Data are expressed as means +SD unless stated otherwise. For lifespan analyses, statistical calculations were performed using JMP software (SAS Institute Inc., Cary, NC, USA), applying the log-rank test. Median and mean survival was calculated by log-rank test for each of the technical replicates in one experiment (i.e. biological replicate). Maximum lifespan in each technical replicate was defined as the last day on which a worm was scored as alive. Mean maximum lifespan for each biological replicate was then determined as the mean of all technical replicates. All other calculations were performed using GraphPad Prism (GraphPad Software, San Diego, California, USA). Statistical significances were calculated using one-way ANOVA (with Bonferroni post-test), Mann-Whitney test, or t-test where appropriate. The minimum level of significance was set to p < 0.05.
2.14. Data availability
The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus [29] and are accessible through GEO Series accession number GSE134196 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE134196).
3. Results and discussion
3.1. Y37A1B.5 is a C. elegans ortholog of SELENBP1, affecting stress resistance and lifespan
We conducted a BLAST search of the C. elegans non-redundant protein sequence database for homologs of human SELENBP1 (GenBank accession# CAG33133). Y37A1B.5 is the C. elegans protein most similar in primary structure to SELENBP1, with 52% identity in amino acid sequence. Several conserved regions were identified by multiple sequence alignment of Y37A1B.5 with human SELENBP1 and its homologs in two other non-mammalian species, Drosophila melanogaster and Danio rerio (Fig. 1). One example is Cys57, corresponding to Cys57 in SELENBP1 (highlighted in black in Fig. 1). Cys57 was hypothesized to be involved in Se binding [15] and demonstrated to be a crucial determinant of stability and effects of overexpressed SELENBP1 in cultured cells [30]. Further conserved motifs include a thioredoxin motif [31,32] present at the active site of redoxin family proteins (CxxC, transparent box in Fig. 1) [33], and histidine-containing metal binding motifs (HxD, HxxH, gray background in Fig. 1) [32,34].
Next, we tested whether expression of Y37A1B.5 may be altered in relation to worm age, and whether it affects C. elegans lifespan. For this purpose, we determined Y37A1B.5 mRNA levels during the course of C. elegans adulthood, followed by analysis of the consequences of Y37A1B.5 knockdown by RNA interference (RNAi).
Y37A1B.5 gene expression exponentially declines over the course of C. elegans adulthood, i.e. from the first day of adulthood to 20 days post adulthood (Fig. 2 A, B). Depletion of Y37A1B.5 through RNAi, i.e. imitation of the later-age situation with respect to Y37A1B.5 expression, resulted in an enhanced lifespan (Fig. 2C), with a significant extension of both mean and maximum lifespan (Fig. 2D; see Table 2 for details). Using RNAi, we achieved Y37A1B.5 knockdown to yield mRNA levels of approx. 10 % of control (2 and 13% on days 3 and 5, respectively; Fig. 2E).
These data suggest that, whereas Y37A1B.5 expression may be dispensable for C. elegans at a later age, it appears to be required in early life, as knockdown of Y37A1B.5 from egg does not lead to an unambiguous (reproducible) extension of lifespan, although no overt adverse effects of deficiency were noticed either (Table 2). The data also suggest that expression of Y37A1B.5 comes at a cost, as knocking down Y37A1B.5 in young adults causes an extension of lifespan.
We therefore sought for potential beneficial effects of Y37A1B.5. As SELENBP1 was originally detected as a protein binding Se in mice injected with high doses of selenite [11], we tested for the role of Y37A1B.5 in C. elegans exposed to 10, 20 or 30 mM selenite, which was shown before to be a concentration range toxic to the nematodes [9]. As demonstrated in Fig. 2F, C. elegans is significantly more sensitive to selenite at all tested concentrations upon knockdown of Y37A1B.5 by RNAi, suggesting a protective role of the protein against acutely toxic Se exposure.
In summary, Y37A1B.5 is an ortholog of human SELENBP1 that protects C. elegans against selenite toxicity. Conversely, its downregulation enhances C. elegans lifespan.
3.2. Y37A1B.5 is a cytoplasmic protein predominantly expressed in hypodermal cells
We then set out to further characterize the expression pattern of Y37A1B.5 and the physiological consequences thereof in the absence of added Se. To this end, we generated a translational fusion construct harboring 3 kb of Y37A1B.5 endogenous promoter region plus the complete ORF fused to GFP (pY37A1B.5::Y37A1B.5::gfp), as depicted in Fig. 3A. Microscopic analysis of adult transgenic worms shows that GFP fluorescence is most prominent in hypodermal cells (Fig. 3B). Subcellularly, Y37A1B.5:GFP is found predominantly in the cytoplasm (Fig. 3C), which is true also for human SELENBP1 [12]. Sporadically, in few worms only, GFP fluorescence is also detected in some anterior or posterior intestinal cells (Fig. 3D).
As demonstrated in Fig. 3E, the RNAi approach chosen to analyze the effect of Y37A1B.5 on lifespan (Fig. 2) also effectively downregulated expression of the transgenic fusion protein as indicated by attenuated overall Y37A1B.5::GFP fluorescence.
3.3. Depletion of Y37A1B.5 enhances stress resistance and improves physiological parameters
In order to test whether the extended lifespan of worms following Y37A1B.5 downregulation was accompanied by a change in resistance to stressful stimuli other than selenite, we exposed the nematodes to a lethal dose (300 mM) of the redox cycler paraquat. Surprisingly, and in contrast to the selenite exposure, after RNAi treatment for six days, Y37A1B.5-deficient worms exhibited a significantly better survival under paraquat exposure than worms fed with control RNAi (Fig. 4A and B; for details, see Table 3).
Table 3.
Exp. No. | Strain, Treatment | Effect on Survival | P (vs. Ctrl)a | Median Survial (h) | Mean Survival (h ± SEM) | Mean Survival (%) | No. of Uncensored Worms | Total No. of Worms |
---|---|---|---|---|---|---|---|---|
1 | N2 /L4440 | 5 | 5.6 ± 0.2 | 100 | 69 | 80 | ||
N2 /Y37A1B.5 | = | p = 0.0556 | 6 | 6.2 ±0.1 | 109.9 | 38 | 49 | |
2 | N2 /L4440 | 4 | 5.5 ± 0.2 | 100 | 66 | 79 | ||
N2 /Y37A1B.5 | ↑ | **** | 9 | 8.0 ± 0.2 | 146.9 | 44 | 81 | |
3 (seeFig. 4A) | N2 /L4440 | 7 | 7.1 ± 0.2 | 100 | 70 | 78 | ||
N2 /Y37A1B.5 | ↑ | *** | 9 | 8.2 ± 0.2 | 116.8 | 53 | 76 | |
4 | N2 /L4440 | 8 | 7.8 ± 0.2 | 100 | 81 | 90 | ||
N2 /Y37A1B.5 | ↑ | **** | 10 | 8.8 ± 0.2 | 112.8 | 50 | 85 |
Controls: N2 /L4440; ***P<0.001 ****P<0.0001; n. s., not significant.
Exposure of pY37A1B.5::Y37A1B.5::gfp transgenic worms to another stressful stimulus, arsenite, elicited an attenuation of Y37A1B.5::GFP expression (Fig. 4C and D), suggesting that downregulation of Y37A1B.5 may be part of a general C. elegans stress response.
In line with their elevated stress resistance to paraquat and extended lifespan, the Y37A1B.5-deficient worms generally appeared to be healthier than their wild-type counterparts, particularly at older age. This was indicated also by the improved C. elegans motility upon knockdown of Y37A1B.5 (Fig. 5A). No impairment of C. elegans fecundity was observed under these conditions (Fig. 5B), and there was a trend towards an increased body area and length, particularly at later stages (Fig. 5C and D).
3.4. Analysis of Y37A1B.5 knockdown-induced transcriptome changes
In order to investigate the role of Y37A1B.5 in C. elegans metabolism, we performed gene expression analysis using RNA-Seq. RNA was isolated from C. elegans fed with bacteria expressing the empty RNAi vector L4440 or a Y37A1B.5-specific RNAi plasmid. Three independent experiments were performed (biological replicates), followed by reverse transcription of the RNA and Illumina Sequencing. Analysis for differentially expressed genes (DEGs, Supplemental Table 1) identified 2474 DEGs that are regulated consistently over all three replicates (Fig. 6A).
Clustering of DEGs according to Gene Ontology (GO) terms (Fig. 6B) revealed that Y37A1B.5 is involved in the regulation of metabolic processes, with sulfur compound metabolism and lipid/carbohydrate metabolic processes in prominent positions among the relevant GO terms.
The involvement of Y37A1B.5 in sulfur metabolic processes is expected for an ortholog of SELENBP1 (see Introduction). Its role in lipid and carbohydrate metabolic processes is in line with findings on the link between Selenbp1 with glucose/lipid metabolism in mice [35].
3.5. Y37A1B.5 knockdown-induced lifespan extension is independent of major stress-responsive transcription factors
DAF-16 (the C. elegans ortholog of mammalian FOXO proteins) and SKN-1 (the Nrf2 ortholog) are among the most prominent transcription factors that are known to be involved in the regulation of fuel (glucose/lipid) metabolism and stress response [36,37]. Both contribute to C. elegans resistance under various stress conditions, including exposure to thiol-depleting agents [20]. Lifespan of DAF-16-deficient worms, i.e. daf-16(mu86) mutants (see Fig. 7A, Table 4), is lower than that of wildtype C. elegans, and Y37A1B.5 knockdown extends lifespan to an extent similar to Y37A1B.5 knockdown in wildtype worms (Table 2, Table 4). A similar effect is observed in our preliminary studies with SKN-1-deficient worms [skn-1(zu135)] (n = 1, >200 worms; Table 4, Fig. S4). Unexpectedly, therefore, neither DAF-16 nor SKN-1 appear to be involved in the lifespan extension elicited by Y37A1B.5 knockdown (Fig. 7A, Table 4). Another major regulator of lipid metabolism, NHR-49, a transcription factor analogous to mammalian hepatocyte nuclear factor 4 (HNF4) and peroxisome proliferator-activated receptor α (PPARα), was demonstrated to also be involved in the C. elegans response to oxidative stress [38]. In order to test for a requirement of NHR-49 for lifespan extension by Y37A1B.5 knockdown we used NHR-49-deficient worms, nhr-49(ok2165). Lifespan of these worms is significantly lower than that of wildtype C. elegans (not shown), as previously described. Knockdown of Y37A1B.5 by RNAi, however, strongly enhances mean and maximum lifespan of NHR-49-deficient worms (Fig. 7B) by 27 to 36% and 34 to 43%, respectively (Table 4), i.e. much higher than in daf-16(mu86) and skn-1(zu135) mutants. This suggests that NHR-49, although not contributing to lifespan extension elicited by Y37A1B.5 knockdown, antagonizes the lifespan extending effect of Y37A1B.5 downregulation. Taken together, the transcription factors DAF-16 and NHR-49, and likely also SKN-1, are not involved in the lifespan extension mediated by Y37A1B.5 knockdown.
Table 4.
Exp. No. | Strain, Treatment | Effect on Life Span | P (vs. Ctrl)b | Median Life Span (Days) | Mean Life Span (Days ± SEM)c | Mean Life Span (%) | Max Life Span (days ± SEM)c | Max Life Span (%) | No. of Uncen-sored Worms | Total Number of Worms |
---|---|---|---|---|---|---|---|---|---|---|
Knockdown of Y37A1B.5 in daf-16(mu86) | ||||||||||
1 (see Fig. 7A) | daf-16 /L4440 | 18 | 17.6 ± 0.0 | 100 | 20.8 ± 0.4 | 100 | 311 | 400 | ||
daf-16 /Y37A1B.5 | ↑ | **** | 20 | 19.3 ± 0.1 | 109.9 | 22.4 ± 0.4 | 107.7 | 370 | 400 | |
2 | daf-16 /L4440 | 18 | 18.9 ± 0.1 | 100 | 22.0 ± 0.0 | 100 | 225 | 450 | ||
daf-16 /Y37A1B.5 | ↑ | **** | 20 | 19.8 ± 0.2 | 104.6 | 24.0 ± 0.8 | 109.1 | 259 | 450 | |
Knockdown of Y37A1B.5 in skn-1(zu135) | ||||||||||
1 | skn-1 /L4440 | 17 | 17.4 ± 0.1 | 100 | 19.8 ± 0.4 | 100 | 210 | 231 | ||
skn-1 /Y37A1B.5 | ↑ | **** | 19 | 19.2 ± 0.2 | 110 | 25.8 ± 0.7 | 130.3 | 204 | 230 | |
Knockdown of Y37A1B.5 in nhr-49(ok2165) | ||||||||||
1 | nhr-49 /L4440 | 16 | 15.8 ± 0.2 | 100 | 20.0 ± 0.0 | 100 | 248 | 400 | ||
nhr-49 /Y37A1B.5 | ↑ | **** | 20 | 20.1 ± 0.3 | 127.4 | 26.4 ± 0.7 | 132.0 | 283 | 400 | |
2 (see Fig. 7B) | nhr-49 /L4440 | 16 | 15.9 ± 0.1 | 100 | 19.2 ± 0.4 | 100 | 321 | 400 | ||
nhr-49 /Y37A1B.5 | ↑ | **** | 22 | 21.6 ± 0.1 | 136.4 | 28.0 ± 0.0 | 145.8 | 295 | 400 | |
3 | nhr-49 /L4440 | 16 | 15.4 ± 0.3 | 100 | 20.0 ± 0.0 | 100 | 298 | 316 | ||
nhr-49 /Y37A1B.5 | ↑ | **** | 20 | 20.9 ± 0.2 | 135.3 | 27.5 ± 0.4 | 137.5 | 300 | 320 |
Survival curves for all experiments are provided in Supplemental Figs. Figs. S3–S5.
Controls: daf-16 /L4440; skn-1 /L4440; nhr-49 /L4440; ****P<0.0001.
4-5 technical replicates.
3.6. Expression of Y37A1B.5 is modulated by transcriptional regulators MDT-15 and EGL-27
In order to identify transcriptional regulators of Y37A1B.5 expression, we focused on two factors that are known to be involved in regulating C. elegans stress resistance and lifespan, and, in part, affect lipid metabolism, MDT-15 and EGL-27 [39,40]. MDT-15 is a transcriptional coregulator known to be involved in the regulation of lipid metabolism [39] and required for the C. elegans transcriptional response to (oxidative) stress as elicited by exposure to paraquat or arsenite [41]. EGL-27 is a transcriptional regulator that was shown to confer stress resistance, extending lifespan of C. elegans [40].
Using worms overexpressing pY37A1B.5::Y37A1B.5::gfp (Fig. 3), we tested for an effect of knocking down mdt-15 or egl-27 expression on Y37A1B.5 expression.
RNAi of egl-27 resulted in upregulation of Y37A1B.5::GFP production, implying that EGL-27 is a negative regulator of Y37A1B.5 expression (Fig. 8A). This is in line with the notion that downregulation of Y37A1B.5 enhances stress resistance and lifespan of C. elegans. Y37A1B.5 was previously identified as an EGL-27 target gene whose expression levels are lower in egl-27-deficient cells, and that is upregulated by heat stress only in the presence of EGL-27 [40]. These data contradict our findings on the negative effect of EGL-27 on Y37A1B.5 levels. A possible reason for these differences is that we analyzed for expression at the protein level whereas the data by Xu and Kim [40] refer to analyses at the mRNA level. Another difference is that we used RNAi-mediated downregulation of egl-27, whereas Xu and Kim had egl-27 expression completely inactivated.
Downregulation of mdt-15 using RNAi causes a robust downregulation of Y37A1B.5 (Fig. 8B), suggesting it is directly involved in its transcriptional control. The knockdown of mdt-15 would, according to our data, imitate the RNAi-induced downregulation of Y37A1B.5, eliciting an enhanced stress resistance (Fig. 4) and extending lifespan (Fig. 2). Interestingly, MDT-15 appears to control the expression of lipid metabolism genes and the nematodal oxidative stress response by interacting with both NHR-49 and SKN-1 [38,41]. Knockdown of Y37A1B.5, however, did not affect mdt-15 or egl-27 mRNA levels (Fig. 8C).
In summary, Y37A1B.5 expression is negatively regulated by EGL-27 and stimulated by MDT-15 (Fig. 8D).
4. Conclusions
Y37A1B.5, a protein hitherto uncharacterized, is a C. elegans ortholog of SELENBP1 that allows for a better survival of nematodes exposed to toxic selenite concentrations, while it is dispensable for adult worms grown under standard laboratory conditions. In fact, knockdown of Y37A1B.5 in young adult C. elegans even resulted in an increased lifespan and resistance against oxidative stress. These effects are associated with changes in the C. elegans transcriptome that suggest a contribution of sulfur metabolic processes and of fuel metabolism. Surprisingly, the transcription factors DAF-16 and NHR-49, which are prominent regulators of fuel metabolism and stress resistance in C. elegans, are not involved in the lifespan extension mediated by Y37A1B.5 knockdown. However, we identify two novel regulators of Y37A1B.5 expression, which is negatively regulated by EGL-27 and positively regulated by MDT-15.
Our findings on Y37A1B.5 conferring selenite resistance, and its downregulation contributing to oxidative stress resistance and lifespan extension are in line with observations on the human ortholog: SELENBP1 sequesters supplemental Se, and its downregulation in tumor cells decreases their sensitivity to cytotoxic effects of oxidative stressors such as H2O2 and paraquat [42]. On the other hand, expression of Y37A1B.5 can be advantageous for free-living nematodes, as they are widely spread geobionts and thus have to cope with large variations in the Se content of soils world-wide, ranging from 0.01 to 1200 mg Se/kg [2].
Acknowledgements
This research was funded by Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany) through Research Training Group “ProMoAge” (RTG 2155, to C.K. and L.O.K.) and, in early stages, by Friedrich-Schiller-Universität Jena through start-up funds to L.O.K.. We gratefully acknowledge Dr. Karol Szafranski (Core Facility Life Science Computing, Leibniz Institute on Aging, Jena) for discussion and Dr. Marco Groth (Core Facility DNA Sequencing, Leibniz Institute on Aging, Jena) for technological support.
Footnotes
Supplementary data to this article can be found online at https://doi.org/10.1016/j.redox.2019.101323.
Appendix A. Supplementary data
The following are the Supplementary data to this article:
References
- 1.Brigelius-Flohé R., Flohé L. Selenium and redox signaling. Arch. Biochem. Biophys. 2017;617:48–59. doi: 10.1016/j.abb.2016.08.003. [DOI] [PubMed] [Google Scholar]
- 2.Fairweather-Tait S.J., Bao Y., Broadley M.R., Collings R., Ford D., Hesketh J.E., Hurst R. Selenium in human health and disease. Antioxidants Redox Signal. 2011;14:1337–1383. doi: 10.1089/ars.2010.3275. [DOI] [PubMed] [Google Scholar]
- 3.Steinbrenner H., Speckmann B., Klotz L.O. Selenoproteins: antioxidant selenoenzymes and beyond. Arch. Biochem. Biophys. 2016;595:113–119. doi: 10.1016/j.abb.2015.06.024. [DOI] [PubMed] [Google Scholar]
- 4.Kryukov G.V., Castellano S., Novoselov S.V., Lobanov A.V., Zehtab O., Guigo R., Gladyshev V.N. Characterization of mammalian selenoproteomes. Science. 2003;300:1439–1443. doi: 10.1126/science.1083516. [DOI] [PubMed] [Google Scholar]
- 5.Taskov K., Chapple C., Kryukov G.V., Castellano S., Lobanov A.V., Korotkov K.V., Guigo R., Gladyshev V.N. Nematode selenoproteome: the use of the selenocysteine insertion system to decode one codon in an animal genome? Nucleic Acids Res. 2005;33:2227–2238. doi: 10.1093/nar/gki507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Stenvall J., Fierro-Gonzalez J.C., Swoboda P., Saamarthy K., Cheng Q., Cacho-Valadez B., Arner E.S., Persson O.P., Miranda-Vizuete A., Tuck S. Selenoprotein TRXR-1 and GSR-1 are essential for removal of old cuticle during molting in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A. 2011;108:1064–1069. doi: 10.1073/pnas.1006328108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Li W., Bandyopadhyay J., Hwaang H.S., Park B.J., Cho J.H., Lee J.I., Ahnn J., Lee S.K. Two thioredoxin reductases, trxr-1 and trxr-2, have differential physiological roles in Caenorhabditis elegans. Mol. Cells. 2012;34:209–218. doi: 10.1007/s10059-012-0155-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Boehler C.J., Raines A.M., Sunde R.A. Deletion of thioredoxin reductase and effects of selenite and selenate toxicity in Caenorhabditis elegans. PLoS One. 2013;8 doi: 10.1371/journal.pone.0071525. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Rohn I., Marschall T.A., Kroepfl N., Jensen K.B., Aschner M., Tuck S., Kuehnelt D., Schwerdtle T., Bornhorst J. Selenium species-dependent toxicity, bioavailability and metabolic transformations in Caenorhabditis elegans. Metallomics. 2018;10:818–827. doi: 10.1039/c8mt00066b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Papp L.V., Lu J., Holmgren A., Khanna K.K. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxidants Redox Signal. 2007;9:775–806. doi: 10.1089/ars.2007.1528. [DOI] [PubMed] [Google Scholar]
- 11.Bansal M.P., Oborn C.J., Danielson K.G., Medina D. Evidence for two selenium-binding proteins distinct from glutathione peroxidase in mouse liver. Carcinogenesis. 1989;10:541–546. doi: 10.1093/carcin/10.3.541. [DOI] [PubMed] [Google Scholar]
- 12.Steinbrenner H., Micoogullari M., Hoang N.A., Bergheim I., Klotz L.O., Sies H. Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes. Redox Biol. 2019;20:489–495. doi: 10.1016/j.redox.2018.11.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Li T., Yang W., Li M., Byun D.S., Tong C., Nasser S., Zhuang M., Arango D., Mariadason J.M., Augenlicht L.H. Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. Mol. Nutr. Food Res. 2008;52:1289–1299. doi: 10.1002/mnfr.200700331. [DOI] [PubMed] [Google Scholar]
- 14.Elhodaky M., Diamond A.M. Selenium-binding protein 1 in human health and disease. Int. J. Mol. Sci. 2018;19 doi: 10.3390/ijms19113437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Raucci R., Colonna G., Guerriero E., Capone F., Accardo M., Castello G., Costantini S. Structural and functional studies of the human selenium binding protein-1 and its involvement in hepatocellular carcinoma. Biochim. Biophys. Acta. 2011;1814:513–522. doi: 10.1016/j.bbapap.2011.02.006. [DOI] [PubMed] [Google Scholar]
- 16.Schild F., Kieffer-Jaquinod S., Palencia A., Cobessi D., Sarret G., Zubieta C., Jourdain A., Dumas R., Forge V., Testemale D., Bourguignon J., Hugouvieux V. Biochemical and biophysical characterization of the selenium-binding and reducing site in Arabidopsis thaliana homologue to mammals selenium-binding protein 1. J. Biol. Chem. 2014;289:31765–31776. doi: 10.1074/jbc.M114.571208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wang Y., Fang W., Huang Y., Hu F., Ying Q., Yang W., Xiong B. Reduction of selenium-binding protein 1 sensitizes cancer cells to selenite via elevating extracellular glutathione: a novel mechanism of cancer-specific cytotoxicity of selenite. Free Radic. Biol. Med. 2015;79:186–196. doi: 10.1016/j.freeradbiomed.2014.11.015. [DOI] [PubMed] [Google Scholar]
- 18.Pol A., Renkema G.H., Tangerman A., Winkel E.G., Engelke U.F., de Brouwer A.P.M., Lloyd K.C., Araiza R.S., van den Heuvel L., Omran H., Olbrich H., Oude Elberink M., Gilissen C., Rodenburg R.J., Sass J.O., Schwab K.O., Schafer H., Venselaar H., Sequeira J.S., Op den Camp H.J.M., Wevers R.A. Mutations in SELENBP1, encoding a novel human methanethiol oxidase, cause extraoral halitosis. Nat. Genet. 2018;50:120–129. doi: 10.1038/s41588-017-0006-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Wei Y., Kenyon C. Roles for ROS and hydrogen sulfide in the longevity response to germline loss in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A. 2016;113:E2832–E2841. doi: 10.1073/pnas.1524727113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Urban N., Tsitsipatis D., Hausig F., Kreuzer K., Erler K., Stein V., Ristow M., Steinbrenner H., Klotz L.O. Non-linear impact of glutathione depletion on C. elegans life span and stress resistance. Redox Biol. 2017;11:502–515. doi: 10.1016/j.redox.2016.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Fraser A.G., Kamath R.S., Zipperlen P., Martinez-Campos M., Sohrmann M., Ahringer J. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature. 2000;408:325–330. doi: 10.1038/35042517. [DOI] [PubMed] [Google Scholar]
- 22.Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77:71–94. doi: 10.1093/genetics/77.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Zhang Y., Chen D., Smith M.A., Zhang B., Pan X. Selection of reliable reference genes in Caenorhabditis elegans for analysis of nanotoxicity. PLoS One. 2012;7 doi: 10.1371/journal.pone.0031849. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Bentley D.R., Balasubramanian S., Swerdlow H.P., Smith G.P., Milton J., Brown C.G., Hall K.P., Evers D.J., Barnes C.L., Bignell H.R., Boutell J.M., Bryant J., Carter R.J., Keira Cheetham R., Cox A.J., Ellis D.J., Flatbush M.R., Gormley N.A., Humphray S.J., Irving L.J., Karbelashvili M.S., Kirk S.M., Li H., Liu X., Maisinger K.S., Murray L.J., Obradovic B., Ost T., Parkinson M.L., Pratt M.R., Rasolonjatovo I.M., Reed M.T., Rigatti R., Rodighiero C., Ross M.T., Sabot A., Sankar S.V., Scally A., Schroth G.P., Smith M.E., Smith V.P., Spiridou A., Torrance P.E., Tzonev S.S., Vermaas E.H., Walter K., Wu X., Zhang L., Alam M.D., Anastasi C., Aniebo I.C., Bailey D.M., Bancarz I.R., Banerjee S., Barbour S.G., Baybayan P.A., Benoit V.A., Benson K.F., Bevis C., Black P.J., Boodhun A., Brennan J.S., Bridgham J.A., Brown R.C., Brown A.A., Buermann D.H., Bundu A.A., Burrows J.C., Carter N.P., Castillo N., Chiara E.C.M., Chang, Neil Cooley R., Crake N.R., Dada O.O., Diakoumakos K.D., Dominguez-Fernandez B., Earnshaw D.J., Egbujor U.C., Elmore D.W., Etchin S.S., Ewan M.R., Fedurco M., Fraser L.J., Fuentes Fajardo K.V., Scott Furey W., George D., Gietzen K.J., Goddard C.P., Golda G.S., Granieri P.A., Green D.E., Gustafson D.L., Hansen N.F., Harnish K., Haudenschild C.D., Heyer N.I., Hims M.M., Ho J.T., Horgan A.M., Hoschler K., Hurwitz S., Ivanov D.V., Johnson M.Q., James T., Huw Jones T.A., Kang G.D., Kerelska T.H., Kersey A.D., Khrebtukova I., Kindwall A.P., Kingsbury Z., Kokko-Gonzales P.I., Kumar A., Laurent M.A., Lawley C.T., Lee S.E., Lee X., Liao A.K., Loch J.A., Lok M., Luo S., Mammen R.M., Martin J.W., McCauley P.G., McNitt P., Mehta P., Moon K.W., Mullens J.W., Newington T., Ning Z., Ling Ng B., Novo S.M., O'Neill M.J., Osborne M.A., Osnowski A., Ostadan O., Paraschos L.L., Pickering L., Pike A.C., Pike A.C., Chris Pinkard D., Pliskin D.P., Podhasky J., Quijano V.J., Raczy C., Rae V.H., Rawlings S.R., Chiva Rodriguez A., Roe P.M., Rogers J., Rogert Bacigalupo M.C., Romanov N., Romieu A., Roth R.K., Rourke N.J., Ruediger S.T., Rusman E., Sanches-Kuiper R.M., Schenker M.R., Seoane J.M., Shaw R.J., Shiver M.K., Short S.W., Sizto N.L., Sluis J.P., Smith M.A., Ernest Sohna Sohna J., Spence E.J., Stevens K., Sutton N., Szajkowski L., Tregidgo C.L., Turcatti G., Vandevondele S., Verhovsky Y., Virk S.M., Wakelin S., Walcott G.C., Wang J., Worsley G.J., Yan J., Yau L., Zuerlein M., Rogers J., Mullikin J.C., Hurles M.E., McCooke N.J., West J.S., Oaks F.L., Lundberg P.L., Klenerman D., Durbin R., Smith A.J. Accurate whole human genome sequencing using reversible terminator chemistry. Nature. 2008;456:53–59. doi: 10.1038/nature07517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Simpson J.T., Durbin R. Efficient de novo assembly of large genomes using compressed data structures. Genome Res. 2012;22:549–556. doi: 10.1101/gr.126953.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Kim D., Pertea G., Trapnell C., Pimentel H., Kelley R., Salzberg S.L. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14:R36. doi: 10.1186/gb-2013-14-4-r36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Liao Y., Smyth G.K., Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923–930. doi: 10.1093/bioinformatics/btt656. [DOI] [PubMed] [Google Scholar]
- 28.Love M.I., Huber W., Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Edgar R., Domrachev M., Lash A.E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30:207–210. doi: 10.1093/nar/30.1.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ying Q., Ansong E., Diamond A.M., Yang W. A critical role for cysteine 57 in the biological functions of selenium binding protein-1. Int. J. Mol. Sci. 2015;16:27599–27608. doi: 10.3390/ijms161126043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Jacob C., Giles G.I., Giles N.M., Sies H. Sulfur and selenium: the role of oxidation state in protein structure and function. Angew Chem. Int. Ed. Engl. 2003;42:4742–4758. doi: 10.1002/anie.200300573. [DOI] [PubMed] [Google Scholar]
- 32.Volz J., Bosch F.U., Wunderlin M., Schuhmacher M., Melchers K., Bensch K., Steinhilber W., Schafer K.P., Toth G., Penke B., Przybylski M. Molecular characterization of metal-binding polypeptide domains by electrospray ionization mass spectrometry and metal chelate affinity chromatography. J. Chromatogr. A. 1998:29–37. doi: 10.1016/s0021-9673(97)00877-7. 800. [DOI] [PubMed] [Google Scholar]
- 33.Hanschmann E.M., Godoy J.R., Berndt C., Hudemann C., Lillig C.H. Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. Antioxidants Redox Signal. 2013;19:1539–1605. doi: 10.1089/ars.2012.4599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Fukasawa K.M., Hata T., Ono Y., Hirose J. Metal preferences of zinc-binding motif on metalloproteases. J. Amino Acids. 2011;2011 doi: 10.4061/2011/574816. 7 pages. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Ying Q., Ansong E., Diamond A.M., Lu Z., Yang W., Bie X. Quantitative proteomic analysis reveals that anti-cancer effects of selenium-binding protein 1 in vivo are associated with metabolic pathways. PLoS One. 2015;10 doi: 10.1371/journal.pone.0126285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Klotz L.O., Sanchez-Ramos C., Prieto-Arroyo I., Urbanek P., Steinbrenner H., Monsalve M. Redox regulation of FoxO transcription factors. Redox Biol. 2015;6:51–72. doi: 10.1016/j.redox.2015.06.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Yamamoto M., Kensler T.W., Motohashi H. The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol. Rev. 2018;98:1169–1203. doi: 10.1152/physrev.00023.2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Goh G.Y.S., Winter J.J., Bhanshali F., Doering K.R.S., Lai R., Lee K., Veal E.A., Taubert S. NHR-49/HNF4 integrates regulation of fatty acid metabolism with a protective transcriptional response to oxidative stress and fasting. Aging Cell. 2018;17 doi: 10.1111/acel.12743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Taubert S., Van Gilst M.R., Hansen M., Yamamoto K.R. A Mediator subunit, MDT-15, integrates regulation of fatty acid metabolism by NHR-49-dependent and -independent pathways in C. elegans. Genes Dev. 2006;20:1137–1149. doi: 10.1101/gad.1395406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Xu X., Kim S.K. The GATA transcription factor egl-27 delays aging by promoting stress resistance in Caenorhabditis elegans. PLoS Genet. 2012;8 doi: 10.1371/journal.pgen.1003108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Hu Q., D'Amora D.R., MacNeil L.T., Walhout A.J.M., Kubiseski T.J. The Caenorhabditis elegans oxidative stress response requires the NHR-49 transcription factor. G3 (Bethesda) 2018;8:3857–3863. doi: 10.1534/g3.118.200727. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Zhao C., Zeng H., Wu R.T., Cheng W.H. Loss of selenium-binding protein 1 decreases sensitivity to clastogens and intracellular selenium content in HeLa cells. PLoS One. 2016;11 doi: 10.1371/journal.pone.0158650. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Sievers F., Higgins D.G. Clustal Omega for making accurate alignments of many protein sequences. Protein Sci. 2018;27:135–145. doi: 10.1002/pro.3290. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus [29] and are accessible through GEO Series accession number GSE134196 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE134196).